3rd Circ. Orders Trial In Pharma Fraud Coverage Suit
The Third Circuit on Wednesday revived an insurer's suit seeking to avoid paying $1.1 million in defense costs for a U.S. Securities and Exchange Commission investigation of a pharmaceutical company facing...To view the full article, register now.
Already a subscriber? Click here to view full article